
Loading, please wait...

Loading, please wait...

Medical professionals frequently utilize vascular closure devices (VCDs) to manage femoral arteriotomy following endovascular procedures. While these tools effectively reduce hemostasis time, their influence on vascular closure device hemodynamics remains a critical area of investigation for preventing postoperative complications. A recent study published in the Journal of Endovascular Therapy used numerical simulations to compare the performance of four common VCDs in steady and pulsatile flow conditions.
The research team employed micro-computed tomography and computational fluid dynamics (CFD) to model blood flow patterns in a 3-dimensional environment. Specifically, they examined time-averaged wall shear stress (TAWSS) and the oscillatory shear index (OSI). These metrics provide essential data on how different device designs interact with the vessel wall and surrounding blood flow. Consequently, the researchers could identify flow disturbances that traditional clinical observation might miss.
The simulations revealed that anchor-based devices cause significantly larger flow disturbances compared to suture-based alternatives. Specifically, anchor-based models decreased TAWSS and increased OSI in the wake of the device. However, suture-based devices maintained a more laminar flow profile. These hemodynamic changes in anchor-based devices create an environment that is likely to be pro-thrombotic. Furthermore, the study demonstrated that these effects persist across both idealized straight cylinders and patient-specific femoral artery geometries.
Suture-based devices demonstrated a far more favorable hemodynamic profile in this simulation. These findings suggest that clinicians should prioritize suture-based VCDs for certain clinical scenarios. For instance, patients with a high risk of thrombosis or existing vessel occlusion may benefit from designs that minimize flow disruption. Additionally, the study highlights the importance of geometry in device design, as the presence of an intravascular anchor fundamentally alters the local fluid dynamics.
While the choice of a VCD often depends on multifactorial clinical considerations, this comparative data offers a unique perspective on long-term safety. Physicians should integrate these hemodynamic insights into their decision-making process to optimize patient outcomes. In addition, continued research into 3D modeling will likely refine our understanding of how these devices behave in diverse vascular anatomies.
Anchor-based devices typically protrude into the vessel lumen, causing flow separation in their wake. This reduces wall shear stress and increases flow oscillation, both of which are risk factors for thrombus formation.
Patients with small-diameter femoral arteries or those at higher risk for vessel occlusion may benefit from suture-based devices, as these maintain smoother blood flow patterns.
A high OSI indicates significant fluctuations in the direction of wall shear stress. In vascular biology, high OSI is strongly associated with endothelial cell activation and a pro-thrombotic state.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
1. Beltran F et al. Numerical Simulation of Steady and Pulsatile Flows Around Vascular Closure Devices: Implications for Thrombosis. J Endovasc Ther. 2026 Mar 22. doi: 10.1177/15266028261424744. PMID: 41865251.
2. Schulz-Schüpke S, et al. Advancements in Vascular Closure Devices for Effective Hemostasis in Femoral Artery Interventions. NIH.gov. 2022.
3. Abdel-Wahab M, et al. CHOICE-CLOSURE: Plug-Based vs. Suture-Based Closure Device Strategies Post-TAVR. ACC.org. Nov 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A CFD study compares anchor-based vs suture-based VCDs, showing anchor-based devices create pro-thrombotic hemodynamic conditions in the femoral artery....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today